07/04/2026

Espacioteca

Becas y Universidades

Wall Street

1 minuto de lectura

What happened?Shares of Immunovant (NASDAQ: IMVT), a clinical-stage biopharmaceutical company, were down by 43.2% as of 2:57 p.m. EST on...